Medical Research

Bangladesh Confirms Local Zika Virus Outbreak
Clinical & Pharma Bangladesh Confirms Local Zika Virus Outbreak

Health authorities in Bangladesh have officially confirmed a local outbreak of the Zika virus, with ten laboratory-confirmed cases identified in and around the capital city of Dhaka between September and December 2024, providing conclusive evidence of domestic transmission and raising significant

Who Is Enhancing Brevard's Community Services?
Clinical & Pharma Who Is Enhancing Brevard's Community Services?

Across Brevard County, a series of strategic enhancements in key community sectors are quietly reshaping the landscape of local support, from empowering individuals with disabilities to pioneering new frontiers in medical research and personal wellness. These developments, driven by dedicated

Global Prostate Cancer Burden Soars in Older Men
Clinical & Pharma Global Prostate Cancer Burden Soars in Older Men

A comprehensive analysis of global health data collected over three decades has delivered a sobering message about the escalating burden of prostate cancer among men aged 65 and older. This systematic review, which examined trends from 1990 through 2021, reveals a significant and continuous upward

How Do Swine Models Revolutionize Heart Care?
Clinical & Pharma How Do Swine Models Revolutionize Heart Care?

The journey of a life-saving medical device from an engineering concept to a clinical reality is fraught with challenges, particularly in the complex and dynamic environment of the human heart. For the millions suffering from heart failure, the promise of new transcatheter technologies offers a

What Does the NIH See in Bucks County Biotech?
Clinical & Pharma What Does the NIH See in Bucks County Biotech?

A high-stakes convergence of science and policy recently unfolded in Doylestown, Bucks County, as National Institutes of Health (NIH) Director Dr. Jay Bhattacharya accepted an invitation from Congressman Brian Fitzpatrick (PA-1) for a firsthand look at a thriving hub of biomedical innovation. The

Can Aktis Oncology's IPO Revive Biotech Markets?
Clinical & Pharma Can Aktis Oncology's IPO Revive Biotech Markets?

After a period of cautious investor sentiment that chilled the life sciences sector, Aktis Oncology is making a decisive move into the public domain with an initial public offering that could signal a significant turning point for the industry. The company, a specialist in targeted

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later